Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Financial Results:
Dishman Carbogen Amcis Ltd reported Revenues for Q4FY24 of ₹655.00 Crores up from ₹619.00 Crore year on year, a rise of 5.82%.
Total Expenses for Q4FY24 of ₹708.00 Crores up from ₹667.00 Crores year on year, a rise of 6.15%.
Consolidated Net Profit of -₹70.00 Crores from -₹71.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹4.46, from -₹4.51 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.